Table 1.

Clinicopathologic characteristics	Gene array training cohort n=63 (%)	Gene array validation cohort n=222 (%)	Penn TMA cohort n=50 (%)
Mean age at diagnosis (years)	57.2	60.44	59.58
Age SD	10.41	10.05	11.7
Stage III	57 (90.5)	201 (90.5)	44 (88)
Stage IV	6 (9.5)	21 (9.5)	6 (12)
Grade 1	6 (9.5)	4 (1.8)	1 (2)
Grade 2	11 (17.5)	80 (36)	7 (14)
Grade 3	42 (66.7)	136 (61.2)	31 (62)
Unknown grade	4 (6.3)	2 (1)	11 (22)
Optimally debulked	31 (49)	112 (50.5)	29 (58)
Suboptimally debulked	32 (51)	110 (49.5)	21 (42)